The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Designing Hydrogels for On-Demand Therapy
Open accessAbstract
Systemic administration of therapeutic agents has been the preferred approach to treat most pathological conditions, in particular for cancer therapy. This treatment modality is associated with side effects, off-target accumulation, toxicity, and rapid renal and hepatic clearance. Multiple efforts have focused on incorporating targeting moieties into systemic therapeutic vehicles to enhance retention and minimize clearance and side effects. However, only a small percentage of the nanoparticles administered systemically accumulate at the tumor site, leading to poor therapeutic efficacy. This has prompted researchers to call the status quo treatment regimen into question and to leverage new delivery materials and alternative administration routes to improve therapeutic outcomes. Recent approaches rely on the use of local delivery platforms that circumvent the hurdles of systemic delivery. Local administration allows delivery of higher "effective" doses while enhancing therapeutic molecules' stability, minimizing side effects, clearance, and accumulation in the liver and kidneys following systemic administration. Hydrogels have proven to be highly biocompatible materials that allow for versatile design to afford sensing and therapy at the same time. Hydrogels' chemical and physical versatility can be exploited to attain disease-triggered in situ assembly and hydrogel programmed degradation and consequent drug release, and hydrogels can also serve as a biocompatible depot for local delivery of stimuli-responsive therapeutic cargo. We will focus this Account on the hydrogel platform that we have developed in our lab, based on dendrimer amine and dextran aldehyde. This hydrogel is disease-responsive and capable of sensing the microenvironment and reacting in a graded manner to diverse pathologies to render different properties, including tissue adhesion, biocompatibility, hydrogel degradation, and embedded drug release profile. We also studied the degradation kinetics of our stimuli-responsive materials in vivo and analyzed the in vitro conditions under which in vitro-in vivo correlation is attained. Identifying key parameters in the in vivo microenvironment under healthy and disease conditions was key to attaining that correlation. The adhesive capacity of our dendrimer-dextran hydrogel makes it optimal for localized and sustained release of embedded drugs. We demonstrated that it affords the delivery of a range of therapeutics to combat cancer, including nucleic acids, small molecules, and antibody drugs. As a depot for local delivery, it allows a high dose of active biomolecules to be delivered directly at the tumor site. Immunotherapy, a recently blooming area in cancer therapy, may exploit stimuli-responsive hydrogels to impart systemic effects following localized therapy. Local delivery would enable release of the proper drug dose and improve drug bioavailability where needed at the same time creating memory and exerting the therapeutic effect systemically. This Account highlights our perspective on how local and systemic therapies provided by stimuli-responsive hydrogels should be used to impart more precise, long-lasting, and potent therapeutic outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192527 · Cited by 2,389
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
On the importance and mechanisms of burst release in matrix-controlled drug delivery systems
Huang, X., & Brazel, C. S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00248-6 · Cited by 1,813
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Noble Metal Nanoparticles Applications in Cancer
Conde, J., Doria, G., & Baptista, P. (2012) · Journal of Drug Delivery · doi:10.1155/2012/751075 · Cited by 541
Self-citationMacrophages as APC and the Dendritic Cell Myth
Hume, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5829 · Cited by 501
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Zhang, S., Ermann, J., Succi, M. D., Zhou, A., Hamilton, M. J., Cao, B., Korzenik, J. R., Glickman, J. N., Vemula, P. K., Glimcher, L. H., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5657 · Cited by 467
Conde, J., Oliva, N., Zhang, Y., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4707 · Cited by 449
Self-citationConde, J., Dias, J. T., Grazú, V., Moros, M., Baptista, P. V., & de la Fuente, J. M. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00048 · Cited by 425
Self-citationLight-Activated Hydrogel Formation via the Triggered Folding and Self-Assembly of a Designed Peptide
Haines, L. A., Rajagopal, K., Ozbas, B., Salick, D. A., Pochan, D. J., & Schneider, J. P. (2005) · Journal of the American Chemical Society · doi:10.1021/ja054719o · Cited by 382
Hydrogels and Scaffolds for Immunomodulation
Singh, A., & Peppas, N. A. (2014) · Advanced Materials · doi:10.1002/adma.201402105 · Cited by 355
Conde, J., Oliva, N., Atilano, M., Song, H. S., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4497 · Cited by 283
Self-citationDixit, S., Novak, T., Miller, K., Zhu, Y., Kenney, M. E., & Broome, A.-M. (2015) · Nanoscale · doi:10.1039/c4nr04853a · Cited by 262
Artzi, N., Oliva, N., Puron, C., Shitreet, S., Artzi, S., bon Ramos, A., Groothuis, A., Sahagian, G., & Edelman, E. R. (2011) · Nature Materials · doi:10.1038/nmat3095 · Cited by 234
Self-citationDesign of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
Conde, J., Ambrosone, A., Sanz, V., Hernandez, Y., Marchesano, V., Tian, F., Child, H., Berry, C. C., Ibarra, M. R., Baptista, P. V., et al. (2012) · ACS Nano · doi:10.1021/nn3030223 · Cited by 232
Self-citationCan Controversial Nanotechnology Promise Drug Delivery?
Devadasu, V. R., Bhardwaj, V., & Kumar, M. N. V. R. (2013) · Chemical Reviews · doi:10.1021/cr300047q · Cited by 210
Injectable block copolymer hydrogels for sustained release of a PEGylated drug
Yu, L., Chang, G. T., Zhang, H., & Ding, J. D. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.026 · Cited by 197
Local microRNA delivery targets Palladin and prevents metastatic breast cancer
Gilam, A., Conde, J., Weissglas-Volkov, D., Oliva, N., Friedman, E., Artzi, N., & Shomron, N. (2016) · Nature Communications · doi:10.1038/ncomms12868 · Cited by 186
Self-citationInjectable dendritic cell-carrying alginate gels for immunization and immunotherapy
Hori, Y., Winans, A. M., Huang, C. C., Horrigan, E. M., & Irvine, D. J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.05.033 · Cited by 175
Gajanayake, T., Olariu, R., Leclère, F. M., Dhayani, A., Yang, Z., Bongoni, A. K., Banz, Y., Constantinescu, M. A., Karp, J. M., Vemula, P. K., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008778 · Cited by 171
FTIR and circular dichroism spectroscopic study of interaction of 5-fluorouracil with DNA
Jangir, D. K., Charak, S., Mehrotra, R., & Kundu, S. (2011) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2011.08.003 · Cited by 160
Muraoka, D., Harada, N., Hayashi, T., Tahara, Y., Momose, F., Sawada, S., Mukai, S., Akiyoshi, K., & Shiku, H. (2014) · ACS Nano · doi:10.1021/nn502975r · Cited by 151
Monette, A., Ceccaldi, C., Assaad, E., Lerouge, S., & Lapointe, R. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.021 · Cited by 143
Yu, L., Zhang, Z., Zhang, H., & Ding, J. (2009) · Biomacromolecules · doi:10.1021/bm900145g · Cited by 141
Composite Nanoparticles Take Aim at Cancer
Rivera-Gil, P., & Parak, W. J. (2008) · ACS Nano · doi:10.1021/nn800716j · Cited by 140
Conde, J., Oliva, N., & Artzi, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421229112 · Cited by 139
Self-citationZhang, H., Yu, L., & Ding, J. (2008) · Macromolecules · doi:10.1021/ma7026484 · Cited by 128
Injectable, Pore‐Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells
Verbeke, C. S., & Mooney, D. J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500618 · Cited by 118
Chen, L., Ci, T., Yu, L., & Ding, J. (2015) · Macromolecules · doi:10.1021/acs.macromol.5b00168 · Cited by 117
Chen, L., Ci, T., Li, T., Yu, L., & Ding, J. (2014) · Macromolecules · doi:10.1021/ma501110p · Cited by 111
Hydrogel Assembly with Hierarchical Alignment by Balancing Electrostatic Forces
Lü, Q., Bai, S., Ding, Z., Guo, H., Shao, Z., Zhu, H., & Kaplan, D. L. (2016) · Advanced Materials Interfaces · doi:10.1002/admi.201500687 · Cited by 108
Conde, J., Bao, C., Cui, D., Baptista, P. V., & Tian, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.045 · Cited by 103
Self-citationConde, J., Rosa, J., de la Fuente, J. M., & Baptista, P. V. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.015 · Cited by 97
Self-citationMolecular Imaging Applications in Nanomedicine
Li, K. C., Pandit, S. D., Guccione, S., & Bednarski, M. D. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000031747.05317.81 · Cited by 90
Gao, J., Xia, Y., Chen, H., Yu, Y., Song, J., Li, W., Qian, W., Wang, H., Dai, J., & Guo, Y. (2013) · Nanomedicine · doi:10.2217/nnm.13.20 · Cited by 85
Oliva, N., Solanes, M. C., Beckerman, M., Seliktar, S., Hayward, A. M., Stanley, J., Parry, N. M., Edelman, E. R., & Artzi, N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1616 · Cited by 79
Self-citationA Promising Road with Challenges: Where Are Gold Nanoparticles in Translational Research?
Bao, C., Conde, J., Polo, E., del Pino, P., Moros, M., Baptista, P. V., Grazú, V., Cui, D., & de la Fuente, J. M. (2014) · Nanomedicine · doi:10.2217/nnm.14.155 · Cited by 69
Self-citationElias, P. Z., Liu, G. W., Wei, H., Jensen, M. C., Horner, P. J., & Pun, S. H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.003 · Cited by 67
Advances in an active and passive targeting to tumor and adipose tissues
Sakurai, Y., Kajimoto, K., Hatakeyama, H., & Harashima, H. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.955847 · Cited by 59
Nanoparticles for Improved Therapeutics and Imaging in Cancer Therapy
Chithrani, D. B. (2010) · Recent Patents on Nanotechnology · doi:10.2174/187221010792483726 · Cited by 55
Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Shimada, T., Ueda, M., Jinno, H., Chiba, N., Wada, M., Watanabe, J., Ishihara, K., & Kitagawa, Y. (2009) · PubMed · Cited by 43
Natural Tissue Microenvironmental Conditions Modulate Adhesive Material Performance
Oliva, N., Shitreet, S., Abraham, E., Stanley, B., Edelman, E. R., & Artzi, N. (2012) · Langmuir · doi:10.1021/la303155p · Cited by 40
Self-citation
Cited by
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
Tang, Z., Liu, Y., He, M., & Bu, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201805664 · Cited by 1,951
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Self-citationStimuli‐Responsive Biomolecule‐Based Hydrogels and Their Applications
Vázquez‐González, M., & Willner, I. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201907670 · Cited by 444
Zhang, K., Feng, Q., Fang, Z., Gu, L., & Bian, L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00071 · Cited by 394
Metadata
- Authors
- Oliva, N., Conde, J., Wang, K., & Artzi, N.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-03-16
- Volume
- 50
- Issue
- 4
- Pages
- 669-679
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2596533219
- Cited by
- 371
- References
- 45
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.